Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.22.0.1
Stock-Based Compensation (Tables)
9 Months Ended
Dec. 31, 2021
Stock-Based Compensation  
Summary of stock-based compensation expense by statement of operations line item

The following table summarizes, by condensed consolidated statements of operations line item, stock-based compensation expense (in thousands):

Three Months Ended

Nine Months Ended

December 31,

December 31,

    

2021

    

2020

    

2021

    

2020

 

Cost of goods sold

$

29

    

$

22

$

86

    

$

59

Research and development

 

22

 

11

 

57

 

29

Selling, general and administrative

 

284

 

216

 

830

 

590

Stock-based compensation expense

$

335

$

249

$

973

$

678

Summary of stock option activity

Weighted

Average Grant

Date Fair

Restricted Stock Units and Performance Restricted Stock Units

Shares

Value

 

Non-vested restricted stock units outstanding at March 31, 2021

    

497,281

    

$

5.65

Granted

 

318,713

5.45

Vested and issued

 

(155,330)

5.13

Forfeited

 

(11,930)

5.60

Non-vested restricted stock units outstanding at December 31, 2021

 

648,734

5.68

Restricted stock units expected to vest beyond December 31, 2021

 

648,734

$

5.68

Summary of restricted stock activity

Three Months Ended December 31,

Nine Months Ended December 31,

    

2021

    

2020

    

2021

    

2020

Restricted stock compensation expense (in thousands)

$

335

    

$

249

    

$

973

    

$

678

Aggregate fair value of restricted stock units vested and issued (in thousands)

$

94

    

$

87

    

$

798

    

$

352

Weighted average grant date fair value of restricted stock units granted during the period

$

4.70

    

$

6.22

    

$

5.45

    

$

4.39